small molecule

E.E.S. 200

ERYTHROMYCIN ETHYLSUCCINATE

Loss of exclusivity—loss of exclusivity

CompanyARBOR PHARMACEUTICALS LLC

Drug detail

Brand name	E.E.S. 200
Active ingredient	ERYTHROMYCIN ETHYLSUCCINATE
Strength	EQ 200MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons
Dosage form	SUSPENSION
Route	ORAL
Modality	Small molecule
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.